Pharmacological and toxicological evaluations of the new pyrazole compound (LQFM-021) as potential analgesic and anti-inflammatory agents View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-09-26

AUTHORS

Iziara F. Florentino, Daiany P. B. da Silva, José Luís R. Martins, Taciane S. da Silva, Fernanda C. A. Santos, Carlos R. Tonussi, Géssica A. Vasconcelos, Boniek G. Vaz, Luciano M. Lião, Ricardo Menegatti, Elson A. Costa

ABSTRACT

Chronic inflammation is a world health problem. There is a need to develop new anti-inflammatory and analgesic drugs with improved activity and reduced side effects. In this context, the aim of this study was to evaluate the antinociceptive and anti-inflammatory effects of the pyrazole compound LQFM-021 after acute and sub-chronic administration in rats submitted to a CFA-induced chronic arthritis model, as well as compare the toxicity of this compound to that of dipyrone, given throughout 7 days. Firstly, we observed that acute oral administration of the higher dose (130 µmol/kg) of LQFM-021 reduced paw lifting time (PET) and edema formation. These effects disappeared on the following day, requiring another dose to maintain the effects. This dose also promoted reduction of the polymorphonuclear recruitment in the synovial fluid. In another experiment, both treatments with LQFM-021, 65 µmol/kg twice a day and 130 µmol/kg once a day, produced a progressive and permanent reduction of the PET and edema, also reducing polymorphonuclear recruitment. However, the single treatment with 130 µmol/kg was more effective than the double treatment with 65 µmol/kg. LQFM-021 did not produce toxicity signs. However, dipyrone (130 µmol/kg once a day) promoted erosion of the epithelial cells and decreased mucus in the gastric mucosa. These data indicate that LQFM-021 produced antinociceptive and anti-inflammatory effects in CFA-induced arthritis in rats. These effects occurred in the absence of apparent toxic effects, indicating that the pyrazole compound LQFM-021 may be considered a good prototype for development of new analgesic/anti-inflammatory drug. More... »

PAGES

265-275

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10787-016-0282-3

DOI

http://dx.doi.org/10.1007/s10787-016-0282-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041749689

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27671330


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Inflammatory Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastric Mucosa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Florentino", 
        "givenName": "Iziara F.", 
        "id": "sg:person.01354525403.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354525403.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "da Silva", 
        "givenName": "Daiany P. B.", 
        "id": "sg:person.015217512601.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015217512601.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martins", 
        "givenName": "Jos\u00e9 Lu\u00eds R.", 
        "id": "sg:person.01173020171.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173020171.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, SC, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411237.2", 
          "name": [
            "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, SC, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "da Silva", 
        "givenName": "Taciane S.", 
        "id": "sg:person.011761540603.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011761540603.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Histology, Embryology and Cell Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Department of Histology, Embryology and Cell Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Santos", 
        "givenName": "Fernanda C. A.", 
        "id": "sg:person.014571610542.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014571610542.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, SC, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411237.2", 
          "name": [
            "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, SC, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tonussi", 
        "givenName": "Carlos R.", 
        "id": "sg:person.01316676370.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316676370.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry Institute, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Chemistry Institute, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vasconcelos", 
        "givenName": "G\u00e9ssica A.", 
        "id": "sg:person.013341202661.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013341202661.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry Institute, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Chemistry Institute, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vaz", 
        "givenName": "Boniek G.", 
        "id": "sg:person.01340043167.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340043167.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry Institute, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Chemistry Institute, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li\u00e3o", 
        "givenName": "Luciano M.", 
        "id": "sg:person.01224025502.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224025502.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Medicinal Pharmaceutical Chemistry, Faculty of Pharmacy, Federal University of Goi\u00e1s, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Laboratory of Medicinal Pharmaceutical Chemistry, Faculty of Pharmacy, Federal University of Goi\u00e1s, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Menegatti", 
        "givenName": "Ricardo", 
        "id": "sg:person.0746110531.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746110531.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411195.9", 
          "name": [
            "Department of Pharmacology, Institute of Biological Sciences, Federal University of Goi\u00e1s, Campus Samambaia, Goi\u00e2nia, GO, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Costa", 
        "givenName": "Elson A.", 
        "id": "sg:person.0653540671.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653540671.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01534437", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032541347", 
          "https://doi.org/10.1007/bf01534437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00256-005-0026-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020905770", 
          "https://doi.org/10.1007/s00256-005-0026-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1021077810548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017152493", 
          "https://doi.org/10.1023/a:1021077810548"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-09-26", 
    "datePublishedReg": "2016-09-26", 
    "description": "Chronic inflammation is a world health problem. There is a need to develop new anti-inflammatory and analgesic drugs with improved activity and reduced side effects. In this context, the aim of this study was to evaluate the antinociceptive and anti-inflammatory effects of the pyrazole compound LQFM-021 after acute and sub-chronic administration in rats submitted to a CFA-induced chronic arthritis model, as well as compare the toxicity of this compound to that of dipyrone, given throughout 7\u00a0days. Firstly, we observed that acute oral administration of the higher dose (130\u00a0\u00b5mol/kg) of LQFM-021 reduced paw lifting time (PET) and edema formation. These effects disappeared on the following day, requiring another dose to maintain the effects. This dose also promoted reduction of the polymorphonuclear recruitment in the synovial fluid. In another experiment, both treatments with LQFM-021, 65\u00a0\u00b5mol/kg twice a day and 130\u00a0\u00b5mol/kg once a day, produced a progressive and permanent reduction of the PET and edema, also reducing polymorphonuclear recruitment. However, the single treatment with 130\u00a0\u00b5mol/kg was more effective than the double treatment with 65\u00a0\u00b5mol/kg. LQFM-021 did not produce toxicity signs. However, dipyrone (130\u00a0\u00b5mol/kg once a day) promoted erosion of the epithelial cells and decreased mucus in the gastric mucosa. These data indicate that LQFM-021 produced antinociceptive and anti-inflammatory effects in CFA-induced arthritis in rats. These effects occurred in the absence of apparent toxic effects, indicating that the pyrazole compound LQFM-021 may be considered a good prototype for development of new analgesic/anti-inflammatory drug.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10787-016-0282-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1101677", 
        "issn": [
          "0925-4692", 
          "1568-5608"
        ], 
        "name": "Inflammopharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "keywords": [
      "anti-inflammatory effects", 
      "LQFM-021", 
      "polymorphonuclear recruitment", 
      "chronic arthritis model", 
      "acute oral administration", 
      "sub-chronic administration", 
      "analgesics/anti-inflammatory drugs", 
      "anti-inflammatory agents", 
      "anti-inflammatory drugs", 
      "world health problem", 
      "apparent toxic effects", 
      "chronic inflammation", 
      "arthritis model", 
      "edema formation", 
      "analgesic drugs", 
      "oral administration", 
      "gastric mucosa", 
      "high dose", 
      "side effects", 
      "synovial fluid", 
      "health problems", 
      "toxicity signs", 
      "single treatment", 
      "epithelial cells", 
      "dose", 
      "toxicological evaluation", 
      "toxic effects", 
      "rats", 
      "treatment", 
      "administration", 
      "days", 
      "drugs", 
      "permanent reduction", 
      "double treatment", 
      "arthritis", 
      "edema", 
      "inflammation", 
      "CFA", 
      "mucosa", 
      "dipyrone", 
      "recruitment", 
      "effect", 
      "mucus", 
      "pyrazole compounds", 
      "signs", 
      "toxicity", 
      "reduction", 
      "cells", 
      "PET", 
      "aim", 
      "agents", 
      "absence", 
      "activity", 
      "evaluation", 
      "study", 
      "improved activity", 
      "fluid", 
      "need", 
      "compounds", 
      "data", 
      "development", 
      "good prototype", 
      "time", 
      "formation", 
      "model", 
      "erosion", 
      "context", 
      "experiments", 
      "problem", 
      "prototype", 
      "pyrazole compound LQFM-021", 
      "compound LQFM-021", 
      "new analgesic/anti-inflammatory drug", 
      "new pyrazole compound"
    ], 
    "name": "Pharmacological and toxicological evaluations of the new pyrazole compound (LQFM-021) as potential analgesic and anti-inflammatory agents", 
    "pagination": "265-275", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041749689"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10787-016-0282-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27671330"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10787-016-0282-3", 
      "https://app.dimensions.ai/details/publication/pub.1041749689"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_694.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10787-016-0282-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10787-016-0282-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10787-016-0282-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10787-016-0282-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10787-016-0282-3'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      22 PREDICATES      114 URIs      103 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10787-016-0282-3 schema:about N0fc6aa39ca1e4c52af4f3fec2516c44f
2 N50f1d6e344264dd2a691fc0176738d19
3 N662e614082d0477eae54254018155144
4 N749b77e9dd1b41a9b3ae59bd73e7e7d4
5 N75d64685e6df48f0b4f3131921d5c4bb
6 N840f46fc133747d1af001790a6ed8be2
7 N8c1d6d1ad8b34d96a770a196ff5c289e
8 Nb1886eb71d2b4aaf828cc4f975d4b747
9 Nc5bb8a52ec6c415997489d1b9a8ab521
10 Ne78b5cf6febf4b40a23df76abafae95c
11 Nea76c90bb6df4b0eabf91570f560fa58
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author Nc38c1b1ff1314c0a9858e99138afeb97
15 schema:citation sg:pub.10.1007/bf01534437
16 sg:pub.10.1007/s00256-005-0026-8
17 sg:pub.10.1023/a:1021077810548
18 schema:datePublished 2016-09-26
19 schema:datePublishedReg 2016-09-26
20 schema:description Chronic inflammation is a world health problem. There is a need to develop new anti-inflammatory and analgesic drugs with improved activity and reduced side effects. In this context, the aim of this study was to evaluate the antinociceptive and anti-inflammatory effects of the pyrazole compound LQFM-021 after acute and sub-chronic administration in rats submitted to a CFA-induced chronic arthritis model, as well as compare the toxicity of this compound to that of dipyrone, given throughout 7 days. Firstly, we observed that acute oral administration of the higher dose (130 µmol/kg) of LQFM-021 reduced paw lifting time (PET) and edema formation. These effects disappeared on the following day, requiring another dose to maintain the effects. This dose also promoted reduction of the polymorphonuclear recruitment in the synovial fluid. In another experiment, both treatments with LQFM-021, 65 µmol/kg twice a day and 130 µmol/kg once a day, produced a progressive and permanent reduction of the PET and edema, also reducing polymorphonuclear recruitment. However, the single treatment with 130 µmol/kg was more effective than the double treatment with 65 µmol/kg. LQFM-021 did not produce toxicity signs. However, dipyrone (130 µmol/kg once a day) promoted erosion of the epithelial cells and decreased mucus in the gastric mucosa. These data indicate that LQFM-021 produced antinociceptive and anti-inflammatory effects in CFA-induced arthritis in rats. These effects occurred in the absence of apparent toxic effects, indicating that the pyrazole compound LQFM-021 may be considered a good prototype for development of new analgesic/anti-inflammatory drug.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N0795b15e52fd4e14b2451b5edffbaedb
25 N26f8ed6d9e0b4027b677d19fc0fe796c
26 sg:journal.1101677
27 schema:keywords CFA
28 LQFM-021
29 PET
30 absence
31 activity
32 acute oral administration
33 administration
34 agents
35 aim
36 analgesic drugs
37 analgesics/anti-inflammatory drugs
38 anti-inflammatory agents
39 anti-inflammatory drugs
40 anti-inflammatory effects
41 apparent toxic effects
42 arthritis
43 arthritis model
44 cells
45 chronic arthritis model
46 chronic inflammation
47 compound LQFM-021
48 compounds
49 context
50 data
51 days
52 development
53 dipyrone
54 dose
55 double treatment
56 drugs
57 edema
58 edema formation
59 effect
60 epithelial cells
61 erosion
62 evaluation
63 experiments
64 fluid
65 formation
66 gastric mucosa
67 good prototype
68 health problems
69 high dose
70 improved activity
71 inflammation
72 model
73 mucosa
74 mucus
75 need
76 new analgesic/anti-inflammatory drug
77 new pyrazole compound
78 oral administration
79 permanent reduction
80 polymorphonuclear recruitment
81 problem
82 prototype
83 pyrazole compound LQFM-021
84 pyrazole compounds
85 rats
86 recruitment
87 reduction
88 side effects
89 signs
90 single treatment
91 study
92 sub-chronic administration
93 synovial fluid
94 time
95 toxic effects
96 toxicity
97 toxicity signs
98 toxicological evaluation
99 treatment
100 world health problem
101 schema:name Pharmacological and toxicological evaluations of the new pyrazole compound (LQFM-021) as potential analgesic and anti-inflammatory agents
102 schema:pagination 265-275
103 schema:productId N3868b04cd7464cb281db09a14bf86132
104 Na4ad20faf76747388335bf048d3ce80f
105 Nfa7913e9e0864ae79b43712c6bc44eed
106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041749689
107 https://doi.org/10.1007/s10787-016-0282-3
108 schema:sdDatePublished 2022-01-01T18:39
109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
110 schema:sdPublisher N96693ec069db455ba78603ebeba85981
111 schema:url https://doi.org/10.1007/s10787-016-0282-3
112 sgo:license sg:explorer/license/
113 sgo:sdDataset articles
114 rdf:type schema:ScholarlyArticle
115 N0795b15e52fd4e14b2451b5edffbaedb schema:issueNumber 5
116 rdf:type schema:PublicationIssue
117 N0fc6aa39ca1e4c52af4f3fec2516c44f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Anti-Inflammatory Agents
119 rdf:type schema:DefinedTerm
120 N26f8ed6d9e0b4027b677d19fc0fe796c schema:volumeNumber 24
121 rdf:type schema:PublicationVolume
122 N3868b04cd7464cb281db09a14bf86132 schema:name dimensions_id
123 schema:value pub.1041749689
124 rdf:type schema:PropertyValue
125 N467ba9241f6643e7b3e80a9db47f5cfb rdf:first sg:person.013341202661.80
126 rdf:rest N56599ff1b93b4608b616639fef3f2ea5
127 N50f1d6e344264dd2a691fc0176738d19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Animals
129 rdf:type schema:DefinedTerm
130 N516d22b2f243470f9d45a4bae52f8686 rdf:first sg:person.011761540603.31
131 rdf:rest Nd0f2fd437242478593784b7e754cb9cd
132 N56599ff1b93b4608b616639fef3f2ea5 rdf:first sg:person.01340043167.49
133 rdf:rest N997a0891e4624124a11acbe712906c7f
134 N5b8f0d5878b14926b3cac7176b68ac24 rdf:first sg:person.0746110531.10
135 rdf:rest Nfb931b6c5a164b0ba580f8099b18ea4f
136 N63af1f01477f49ffb6bfa8f460f29094 rdf:first sg:person.01316676370.26
137 rdf:rest N467ba9241f6643e7b3e80a9db47f5cfb
138 N662e614082d0477eae54254018155144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Pyrazoles
140 rdf:type schema:DefinedTerm
141 N749b77e9dd1b41a9b3ae59bd73e7e7d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Gastric Mucosa
143 rdf:type schema:DefinedTerm
144 N75d64685e6df48f0b4f3131921d5c4bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Female
146 rdf:type schema:DefinedTerm
147 N785400c34d294e37bcacbc63141e75b5 rdf:first sg:person.01173020171.60
148 rdf:rest N516d22b2f243470f9d45a4bae52f8686
149 N840f46fc133747d1af001790a6ed8be2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Arthritis, Experimental
151 rdf:type schema:DefinedTerm
152 N8c1d6d1ad8b34d96a770a196ff5c289e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Analgesics
154 rdf:type schema:DefinedTerm
155 N96693ec069db455ba78603ebeba85981 schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 N997a0891e4624124a11acbe712906c7f rdf:first sg:person.01224025502.22
158 rdf:rest N5b8f0d5878b14926b3cac7176b68ac24
159 Na4ad20faf76747388335bf048d3ce80f schema:name doi
160 schema:value 10.1007/s10787-016-0282-3
161 rdf:type schema:PropertyValue
162 Nb1886eb71d2b4aaf828cc4f975d4b747 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Rats, Wistar
164 rdf:type schema:DefinedTerm
165 Nc38c1b1ff1314c0a9858e99138afeb97 rdf:first sg:person.01354525403.69
166 rdf:rest Nd0c4767248a7465ea6924890f65fdec1
167 Nc5bb8a52ec6c415997489d1b9a8ab521 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Tetrazoles
169 rdf:type schema:DefinedTerm
170 Nd0c4767248a7465ea6924890f65fdec1 rdf:first sg:person.015217512601.43
171 rdf:rest N785400c34d294e37bcacbc63141e75b5
172 Nd0f2fd437242478593784b7e754cb9cd rdf:first sg:person.014571610542.43
173 rdf:rest N63af1f01477f49ffb6bfa8f460f29094
174 Ne78b5cf6febf4b40a23df76abafae95c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Rats
176 rdf:type schema:DefinedTerm
177 Nea76c90bb6df4b0eabf91570f560fa58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Dose-Response Relationship, Drug
179 rdf:type schema:DefinedTerm
180 Nfa7913e9e0864ae79b43712c6bc44eed schema:name pubmed_id
181 schema:value 27671330
182 rdf:type schema:PropertyValue
183 Nfb931b6c5a164b0ba580f8099b18ea4f rdf:first sg:person.0653540671.36
184 rdf:rest rdf:nil
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
189 schema:name Pharmacology and Pharmaceutical Sciences
190 rdf:type schema:DefinedTerm
191 sg:journal.1101677 schema:issn 0925-4692
192 1568-5608
193 schema:name Inflammopharmacology
194 schema:publisher Springer Nature
195 rdf:type schema:Periodical
196 sg:person.01173020171.60 schema:affiliation grid-institutes:grid.411195.9
197 schema:familyName Martins
198 schema:givenName José Luís R.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173020171.60
200 rdf:type schema:Person
201 sg:person.011761540603.31 schema:affiliation grid-institutes:grid.411237.2
202 schema:familyName da Silva
203 schema:givenName Taciane S.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011761540603.31
205 rdf:type schema:Person
206 sg:person.01224025502.22 schema:affiliation grid-institutes:grid.411195.9
207 schema:familyName Lião
208 schema:givenName Luciano M.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224025502.22
210 rdf:type schema:Person
211 sg:person.01316676370.26 schema:affiliation grid-institutes:grid.411237.2
212 schema:familyName Tonussi
213 schema:givenName Carlos R.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316676370.26
215 rdf:type schema:Person
216 sg:person.013341202661.80 schema:affiliation grid-institutes:grid.411195.9
217 schema:familyName Vasconcelos
218 schema:givenName Géssica A.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013341202661.80
220 rdf:type schema:Person
221 sg:person.01340043167.49 schema:affiliation grid-institutes:grid.411195.9
222 schema:familyName Vaz
223 schema:givenName Boniek G.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340043167.49
225 rdf:type schema:Person
226 sg:person.01354525403.69 schema:affiliation grid-institutes:grid.411195.9
227 schema:familyName Florentino
228 schema:givenName Iziara F.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354525403.69
230 rdf:type schema:Person
231 sg:person.014571610542.43 schema:affiliation grid-institutes:grid.411195.9
232 schema:familyName Santos
233 schema:givenName Fernanda C. A.
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014571610542.43
235 rdf:type schema:Person
236 sg:person.015217512601.43 schema:affiliation grid-institutes:grid.411195.9
237 schema:familyName da Silva
238 schema:givenName Daiany P. B.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015217512601.43
240 rdf:type schema:Person
241 sg:person.0653540671.36 schema:affiliation grid-institutes:grid.411195.9
242 schema:familyName Costa
243 schema:givenName Elson A.
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653540671.36
245 rdf:type schema:Person
246 sg:person.0746110531.10 schema:affiliation grid-institutes:grid.411195.9
247 schema:familyName Menegatti
248 schema:givenName Ricardo
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746110531.10
250 rdf:type schema:Person
251 sg:pub.10.1007/bf01534437 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032541347
252 https://doi.org/10.1007/bf01534437
253 rdf:type schema:CreativeWork
254 sg:pub.10.1007/s00256-005-0026-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020905770
255 https://doi.org/10.1007/s00256-005-0026-8
256 rdf:type schema:CreativeWork
257 sg:pub.10.1023/a:1021077810548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017152493
258 https://doi.org/10.1023/a:1021077810548
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.411195.9 schema:alternateName Chemistry Institute, Federal University of Goiás, Campus Samambaia, Goiânia, GO, Brazil
261 Department of Histology, Embryology and Cell Biology, Institute of Biological Sciences, Federal University of Goiás, Campus Samambaia, Goiânia, GO, Brazil
262 Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Campus Samambaia, Goiânia, GO, Brazil
263 Laboratory of Medicinal Pharmaceutical Chemistry, Faculty of Pharmacy, Federal University of Goiás, Goiânia, GO, Brazil
264 schema:name Chemistry Institute, Federal University of Goiás, Campus Samambaia, Goiânia, GO, Brazil
265 Department of Histology, Embryology and Cell Biology, Institute of Biological Sciences, Federal University of Goiás, Campus Samambaia, Goiânia, GO, Brazil
266 Department of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Campus Samambaia, Goiânia, GO, Brazil
267 Laboratory of Medicinal Pharmaceutical Chemistry, Faculty of Pharmacy, Federal University of Goiás, Goiânia, GO, Brazil
268 rdf:type schema:Organization
269 grid-institutes:grid.411237.2 schema:alternateName Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, SC, Brazil
270 schema:name Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, SC, Brazil
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...